- Biotech pay analysis: 12 execs with $35M+ M&A golden parachutesA dozen biotech executives took home nearly $1 billion worth of exit packages from selling their companies, an Endpoints News analysis found. The drug industry is undergoing a historic stretch of…Endpoints · 1mo ago↗ source
- AstraZeneca’s ‘extensive’ obesity drug push; $125M for ultrasound-aided genetic medicine<figure><div><img src="https://imgproxy.divecdn.com/idsdMAHsPbXObDUtQW2qRG7uveBUVv6HCTn9NTtlDOI/g:nowe:0:0/c:1207:682/rs:fill:1600:900:1/Z3M6Ly9kaXZlc2l0ZS1zdG9yYWdlL2RpdmVpbWFnZS9HZXR0eUltYWdlcy0x…BioPharma Dive · 1mo ago↗ source
- Ethyreal lands $101M to treat both Graves' and thyroid eye diseaseA biotech backed by Atlas Venture and Medicxi uncloaked on Wednesday morning to tackle the related autoimmune conditions Graves' disease and thyroid eye disease, and the startup plans to enter the…